Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06092554Not ApplicableRecruiting

Probiotics to Actively Counter Ventilator Associated Pneumonia (PROACT)

Role: collaborator

NCT06949748Recruiting

Flecainide in Idiopathic Premature Ventricular Contractions and Related Cardiomyopathy

Role: collaborator

NCT06032988Not ApplicableCompleted

Effect of Probiotic Supplements on Metabolic Control of People With Type 2 Diabetes Mellitus in Greece

Role: collaborator

NCT03074552Not ApplicableCompleted

Probiotic Prophylaxis for Microbiome Modulation and VAP or Infections Prevention in Multitrauma Patients

Role: collaborator

NCT00422617Not ApplicableCompleted

Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients

Role: lead

All 5 trials loaded